General Anesthetic [EPC]

General Anesthetic [EPC] was reported 43600 times

Drugs of the General Anesthetic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 PROPOFOL INFUSION SYNDROME 634 0.8993
1 NEGATIVE PRESSURE PULMONARY OEDEMA 74 0.7551
2 END-TIDAL CO2 INCREASED 34 0.7391
3 TRIGEMINO-CARDIAC REFLEX 59 0.7284
4 ANAESTHETIC COMPLICATION NEUROLOGICAL 621 0.6854
5 UNWANTED AWARENESS DURING ANAESTHESIA 166 0.5061
6 NEUROMUSCULAR BLOCK PROLONGED 174 0.4715
7 AIRWAY PEAK PRESSURE INCREASED 71 0.4671
8 MITOCHONDRIAL DNA MUTATION 39 0.4535
9 DELAYED RECOVERY FROM ANAESTHESIA 416 0.4388
10 HYPERTHERMIA MALIGNANT 625 0.4197
11 ANAESTHETIC COMPLICATION PULMONARY 36 0.4045
12 RECURRENCE OF NEUROMUSCULAR BLOCKADE 66 0.3860
13 AIRWAY COMPLICATION OF ANAESTHESIA 100 0.3802
14 NEW ONSET REFRACTORY STATUS EPILEPTICUS 39 0.3545
15 ANAESTHETIC COMPLICATION CARDIAC 24 0.3478
16 MECHANICAL VENTILATION COMPLICATION 49 0.3289
17 POSTOPERATIVE DELIRIUM 65 0.3283
18 MYOGLOBIN URINE PRESENT 73 0.2967
19 TRACHEAL DEVIATION 24 0.2727
20 ALLERGY TEST NEGATIVE 40 0.2564
21 NEUROMUSCULAR BLOCKADE 57 0.2545
22 BURKHOLDERIA TEST POSITIVE 29 0.2339
23 INTRA-ABDOMINAL PRESSURE INCREASED 36 0.2293
24 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 78 0.2053
25 CSF OLIGOCLONAL BAND PRESENT 25 0.1923
26 PROCEDURAL HYPOTENSION 162 0.1904
27 CONFUSION POSTOPERATIVE 24 0.1832
28 PHAEOCHROMOCYTOMA CRISIS 33 0.1557
29 MYOCARDIAL DEPRESSION 39 0.1512
30 PHRENIC NERVE PARALYSIS 31 0.1416
31 NECROSIS ISCHAEMIC 60 0.1302
32 ANAESTHETIC COMPLICATION 348 0.1295
33 ANAPHYLACTOID SHOCK 57 0.1213
34 HEPATIC ISCHAEMIA 36 0.1158
35 PCO2 INCREASED 82 0.1152
36 CARCINOID CRISIS 25 0.1106
37 TRYPTASE INCREASED 74 0.1036
38 SPINAL MUSCULAR ATROPHY 27 0.1000
39 MATERNAL EXPOSURE DURING DELIVERY 99 0.0999
40 MEAN ARTERIAL PRESSURE DECREASED 24 0.0949
41 OPERATIVE HAEMORRHAGE 42 0.0940
42 INSPIRATORY CAPACITY DECREASED 26 0.0939
43 DIABETES INSIPIDUS 226 0.0938
44 POSTOPERATIVE FEVER 26 0.0929
45 ANAPHYLACTIC SHOCK 2289 0.0887
46 NEONATAL RESPIRATORY DEPRESSION 29 0.0873
47 ENDOTRACHEAL INTUBATION COMPLICATION 51 0.0864
48 PO2 INCREASED 41 0.0809
49 TRANSMISSION OF AN INFECTIOUS AGENT VIA A MEDICINAL PRODUCT 68 0.0802
50 BLOOD GASES ABNORMAL 43 0.0798
51 LARYNGOSPASM 212 0.0788
52 PROCEDURAL VOMITING 51 0.0785
53 LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION 27 0.0776
54 HYPOCAPNIA 32 0.0766
55 ELECTROMECHANICAL DISSOCIATION 61 0.0763
56 RENAL ISCHAEMIA 41 0.0750
57 BRADYCARDIA FOETAL 60 0.0722
58 PNEUMATOSIS 32 0.0717
59 RESPIRATORY ACIDOSIS 281 0.0714
60 PROCEDURAL NAUSEA 56 0.0696
61 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 227 0.0685
62 VASOPLEGIA SYNDROME 112 0.0683
63 HYPERCAPNIA 205 0.0680
64 PRODUCT CONTAMINATION MICROBIAL 81 0.0679
65 BRONCHOSPASM 953 0.0667
66 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 24 0.0661
67 MYOGLOBINURIA 35 0.0657
68 UPPER AIRWAY OBSTRUCTION 58 0.0654
69 SKIN TEST POSITIVE 61 0.0654
70 OPISTHOTONUS 51 0.0642
71 LABILE BLOOD PRESSURE 76 0.0640
72 NEPHROGENIC DIABETES INSIPIDUS 72 0.0624
73 DRUG EFFECT PROLONGED 34 0.0616
74 HYPOXIC ENCEPHALOPATHY 25 0.0610
75 ACIDOSIS HYPERCHLORAEMIC 36 0.0606
76 PULSELESS ELECTRICAL ACTIVITY 252 0.0602
77 AIR EMBOLISM 28 0.0594
78 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 61 0.0574
79 MULTIPLE-DRUG RESISTANCE 178 0.0573
80 KOUNIS SYNDROME 130 0.0572
81 BRUGADA SYNDROME 59 0.0570
82 HAEMODYNAMIC INSTABILITY 422 0.0553
83 STATUS EPILEPTICUS 607 0.0537
84 STRESS CARDIOMYOPATHY 312 0.0536
85 NON-CARDIOGENIC PULMONARY OEDEMA 56 0.0529
86 ANTICHOLINERGIC SYNDROME 83 0.0521
87 CONGESTIVE HEPATOPATHY 23 0.0513
88 SINUS ARREST 80 0.0510
89 HYPOVENTILATION 166 0.0509
90 ISCHAEMIC CEREBRAL INFARCTION 59 0.0508
91 RESPIRATORY TRACT INFECTION BACTERIAL 25 0.0502
92 HEPATORENAL FAILURE 30 0.0498
93 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 109 0.0496
94 MACROGLOSSIA 27 0.0491
95 BLOOD PH DECREASED 81 0.0473
96 UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE 52 0.0473
97 ABDOMINAL COMPARTMENT SYNDROME 30 0.0471
98 SUBCUTANEOUS EMPHYSEMA 46 0.0468
99 CARDIAC OUTPUT DECREASED 41 0.0464
100 PLEOCYTOSIS 26 0.0447
101 APNOEIC ATTACK 25 0.0443
102 PNEUMOCOCCAL SEPSIS 29 0.0441
103 VENTRICULAR FIBRILLATION 483 0.0434
104 SEIZURE LIKE PHENOMENA 73 0.0430
105 DRUG LEVEL CHANGED 27 0.0429
106 RESUSCITATION 71 0.0428
107 CLONUS 117 0.0427
108 ELECTROENCEPHALOGRAM ABNORMAL 134 0.0424
109 ARTERIOSPASM CORONARY 170 0.0423
110 SEROTONIN SYNDROME 805 0.0419
111 FOETAL EXPOSURE DURING DELIVERY 28 0.0413
112 RESPIRATORY DEPRESSION 500 0.0408
113 TONIC CLONIC MOVEMENTS 52 0.0400
114 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 104 0.0397
115 PO2 DECREASED 45 0.0391
116 APNOEA 302 0.0388
117 CLONIC CONVULSION 28 0.0383
118 STRIDOR 112 0.0380
119 SEDATION COMPLICATION 96 0.0376
120 BLOOD PRESSURE IMMEASURABLE 57 0.0372
121 SUSPECTED PRODUCT CONTAMINATION 36 0.0355
122 APGAR SCORE LOW 44 0.0341
123 TORSADE DE POINTES 268 0.0341
124 CIRCULATORY COLLAPSE 577 0.0338
125 ANAPHYLACTIC REACTION 1849 0.0334
126 METHAEMOGLOBINAEMIA 77 0.0332
127 PRINZMETAL ANGINA 33 0.0332
128 INTESTINAL ISCHAEMIA 182 0.0330
129 INTESTINAL PSEUDO-OBSTRUCTION 29 0.0330
130 MYOCLONIC EPILEPSY 49 0.0323
131 PUPILS UNEQUAL 36 0.0314
132 NODAL RHYTHM 46 0.0314
133 HYPERTRIGLYCERIDAEMIA 184 0.0314
134 HEPATORENAL SYNDROME 53 0.0314
135 TYPE I HYPERSENSITIVITY 110 0.0312
136 PERFORATION 25 0.0310
137 BRADYARRHYTHMIA 51 0.0310
138 PROCEDURAL COMPLICATION 237 0.0309
139 VENTRICULAR TACHYCARDIA 509 0.0308
140 MYOCLONUS 367 0.0307
141 BLOOD BICARBONATE DECREASED 58 0.0306
142 SYMMETRICAL DRUG-RELATED INTERTRIGINOUS AND FLEXURAL EXANTHEMA 25 0.0304
143 ENDOTRACHEAL INTUBATION 85 0.0303
144 PULSE ABSENT 144 0.0302
145 PCO2 DECREASED 29 0.0300
146 MULTI-ORGAN FAILURE 505 0.0292
147 HYPERTHERMIA 223 0.0292
148 BRADYCARDIA 1515 0.0285
149 PULMONARY ALVEOLAR HAEMORRHAGE 158 0.0281
150 ANAPHYLACTOID REACTION 115 0.0279
151 ACUTE LUNG INJURY 33 0.0278
152 VENTRICULAR ARRHYTHMIA 101 0.0276
153 BLOOD LACTIC ACID INCREASED 145 0.0275
154 BRAIN HERNIATION 82 0.0274
155 VENTRICULAR HYPOKINESIA 86 0.0267
156 CONTINUOUS HAEMODIAFILTRATION 26 0.0266
157 CARDIAC ARREST 2191 0.0265
158 CARDIOVASCULAR INSUFFICIENCY 43 0.0264
159 GAZE PALSY 45 0.0264
160 ACUTE PULMONARY OEDEMA 144 0.0256
161 MYOGLOBIN BLOOD INCREASED 39 0.0255
162 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 130 0.0253
163 POST PROCEDURAL COMPLICATION 487 0.0253
164 MECHANICAL VENTILATION 48 0.0252
165 MYOCARDIAL INJURY 28 0.0249
166 PUPIL FIXED 43 0.0248
167 RHABDOMYOLYSIS 1034 0.0248
168 PRODUCT CONTAMINATION 88 0.0247
169 AUTONOMIC NERVOUS SYSTEM IMBALANCE 72 0.0246
170 THYROTOXIC CRISIS 28 0.0246
171 GENERALISED ERYTHEMA 140 0.0246
172 NEUROMYOPATHY 26 0.0244
173 OCULOGYRIC CRISIS 52 0.0242
174 BRAIN DEATH 74 0.0239
175 SYSTOLIC DYSFUNCTION 25 0.0237
176 TACHYARRHYTHMIA 59 0.0236
177 HYPERREFLEXIA 82 0.0235
178 HYPERLACTACIDAEMIA 63 0.0235
179 ATRIOVENTRICULAR BLOCK COMPLETE 156 0.0233
180 CONVERSION DISORDER 45 0.0232
181 PARTIAL SEIZURES 121 0.0231
182 HYPERNATRAEMIA 115 0.0231
183 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 88 0.0230
184 HYPORESPONSIVE TO STIMULI 27 0.0230
185 ACIDOSIS 175 0.0229
186 HYPOPERFUSION 24 0.0228
187 HYPOXIA 801 0.0227
188 ATRIOVENTRICULAR BLOCK SECOND DEGREE 69 0.0227
189 INCREASED BRONCHIAL SECRETION 58 0.0227
190 ISCHAEMIC HEPATITIS 31 0.0226
191 AREFLEXIA 60 0.0225
192 NEUROLOGICAL DECOMPENSATION 52 0.0225
193 METABOLIC ACIDOSIS 713 0.0223
194 LONG QT SYNDROME 52 0.0217
195 OLIGURIA 133 0.0214
196 AMYLASE INCREASED 79 0.0214
197 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 165 0.0212
198 TOXIC ENCEPHALOPATHY 107 0.0211
199 SHOCK 484 0.0210
200 HEPATITIS FULMINANT 62 0.0209
201 VENTRICULAR DYSFUNCTION 54 0.0208
202 SUPERINFECTION 31 0.0207
203 LOW BIRTH WEIGHT BABY 164 0.0206
204 PUPILLARY REFLEX IMPAIRED 37 0.0200
205 MUTISM 29 0.0200
206 VENTRICULAR EXTRASYSTOLES 207 0.0199
207 HYPOVOLAEMIA 116 0.0198
208 RESPIRATORY ALKALOSIS 32 0.0197
209 BRAIN OEDEMA 248 0.0196
210 LARYNGEAL OEDEMA 119 0.0193
211 QUADRIPARESIS 32 0.0193
212 GENE MUTATION 38 0.0192
213 HYPERAMMONAEMIC ENCEPHALOPATHY 33 0.0190
214 MUSCLE RIGIDITY 227 0.0190
215 TOXIC EPIDERMAL NECROLYSIS 287 0.0189
216 TORTICOLLIS 40 0.0189
217 ATELECTASIS 182 0.0188
218 PNEUMOMEDIASTINUM 34 0.0188
219 ELECTROCARDIOGRAM T WAVE INVERSION 41 0.0185
220 CARBON DIOXIDE INCREASED 25 0.0183
221 TACHYPNOEA 248 0.0182
222 COMPARTMENT SYNDROME 47 0.0180
223 PRIAPISM 62 0.0180
224 POSTPARTUM HAEMORRHAGE 24 0.0178
225 SINUS BRADYCARDIA 171 0.0177
226 SHOCK HAEMORRHAGIC 144 0.0177
227 MIXED LIVER INJURY 53 0.0176
228 EXTRAVASATION 72 0.0175
229 CARDIOGENIC SHOCK 251 0.0175
230 OXYGEN SATURATION DECREASED 975 0.0173
231 NYSTAGMUS 92 0.0173
232 ACUTE RESPIRATORY DISTRESS SYNDROME 305 0.0172
233 OBSTRUCTIVE SLEEP APNOEA SYNDROME 25 0.0171
234 FEAR 459 0.0170
235 SINUS TACHYCARDIA 242 0.0170
236 OXYGEN SATURATION ABNORMAL 48 0.0169
237 FEAR OF DEATH 38 0.0169
238 MULTIPLE ORGAN DYSFUNCTION SYNDROME 478 0.0169
239 CYTOLYTIC HEPATITIS 56 0.0169
240 HYPOTENSION 3377 0.0168
241 COAGULOPATHY 280 0.0168
242 BLOOD PRESSURE SYSTOLIC DECREASED 75 0.0165
243 SUSPECTED PRODUCT QUALITY ISSUE 30 0.0164
244 TROPONIN INCREASED 124 0.0163
245 BLOOD CREATINE PHOSPHOKINASE INCREASED 469 0.0163
246 SUPRAVENTRICULAR EXTRASYSTOLES 55 0.0163
247 PSEUDOMONAL SEPSIS 28 0.0160
248 SPUTUM INCREASED 34 0.0157
249 GENERALISED TONIC-CLONIC SEIZURE 260 0.0157
250 CHOREA 27 0.0157
251 ATRIOVENTRICULAR BLOCK 121 0.0156
252 TACHYCARDIA 1381 0.0155
253 HEPATOCELLULAR DAMAGE 35 0.0155
254 DISSEMINATED INTRAVASCULAR COAGULATION 218 0.0155
255 HEPATITIS ACUTE 100 0.0154
256 PROCEDURAL HAEMORRHAGE 60 0.0153
257 RESPIRATORY RATE DECREASED 48 0.0153
258 RASH MORBILLIFORM 42 0.0151
259 INTRA-ABDOMINAL HAEMORRHAGE 36 0.0151
260 CHRONIC GASTRITIS 34 0.0150
261 MYDRIASIS 193 0.0150
262 LEFT VENTRICULAR DYSFUNCTION 100 0.0149
263 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 142 0.0149
264 FOETAL DEATH 77 0.0148
265 HEPARIN-INDUCED THROMBOCYTOPENIA 73 0.0148
266 PANCREATITIS NECROTISING 34 0.0148
267 BRONCHIAL DISORDER 23 0.0148
268 NEUROLEPTIC MALIGNANT SYNDROME 175 0.0147
269 PNEUMONIA STAPHYLOCOCCAL 29 0.0147
270 CHEST X-RAY ABNORMAL 45 0.0147
271 PARADOXICAL DRUG REACTION 54 0.0147
272 SUPRAVENTRICULAR TACHYCARDIA 140 0.0146
273 PARAPLEGIA 42 0.0145
274 LEFT VENTRICULAR HYPERTROPHY 62 0.0145
275 HAEMOTHORAX 42 0.0145
276 ACUTE HEPATIC FAILURE 197 0.0144
277 HYPERAMMONAEMIA 72 0.0144
278 LUNG CONSOLIDATION 40 0.0143
279 CYANOSIS 224 0.0142
280 HYPERAEMIA 28 0.0142
281 HYPERKALAEMIA 495 0.0141
282 HAEMODIALYSIS 117 0.0139
283 DYSTONIA 270 0.0139
284 RESPIRATORY ARREST 382 0.0138
285 UNRESPONSIVE TO STIMULI 357 0.0138
286 NEPHROGENIC ANAEMIA 64 0.0138
287 RENAL INJURY 409 0.0138
288 DEAFNESS NEUROSENSORY 45 0.0137
289 HYPOTHERMIA 135 0.0133
290 POLYURIA 109 0.0133
291 COMA SCALE ABNORMAL 38 0.0131
292 ANHEDONIA 341 0.0130
293 ABDOMINAL RIGIDITY 35 0.0129
294 ANURIA 111 0.0129
295 HEPATOCELLULAR INJURY 182 0.0128
296 HEPATIC NECROSIS 48 0.0127
297 QUADRIPLEGIA 26 0.0126
298 ACUTE RESPIRATORY FAILURE 242 0.0126
299 POTENTIATING DRUG INTERACTION 42 0.0125
300 PREMATURE DELIVERY 198 0.0124
301 TRISMUS 64 0.0124
302 ACCIDENTAL DEATH 23 0.0124
303 HYPERPARATHYROIDISM SECONDARY 31 0.0124
304 RENAL FAILURE ACUTE 524 0.0123
305 PREMATURE BABY 371 0.0123
306 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 316 0.0123
307 KLEBSIELLA INFECTION 62 0.0122
308 CEREBRAL ISCHAEMIA 63 0.0122
309 ELECTROCARDIOGRAM QT PROLONGED 439 0.0122
310 NECROTISING FASCIITIS 43 0.0122
311 STUPOR 39 0.0121
312 PERIORBITAL OEDEMA 63 0.0121
313 ENCEPHALOPATHY 295 0.0120
314 HEPATIC CYTOLYSIS 153 0.0120
315 ATRIOVENTRICULAR BLOCK FIRST DEGREE 52 0.0120
316 RESPIRATORY FAILURE 870 0.0119
317 RENAL TUBULAR NECROSIS 117 0.0119
318 DISTRIBUTIVE SHOCK 27 0.0119
319 CARDIO-RESPIRATORY ARREST 498 0.0119
320 HEPATITIS TOXIC 31 0.0119
321 HYPERTONIA 68 0.0119
322 BRADYPNOEA 32 0.0118
323 PATENT DUCTUS ARTERIOSUS 47 0.0118
324 BUNDLE BRANCH BLOCK LEFT 50 0.0118
325 BRAIN INJURY 118 0.0118
326 THERAPEUTIC AGENT TOXICITY 39 0.0117
327 OBSTRUCTIVE AIRWAYS DISORDER 130 0.0117
328 INTRACRANIAL PRESSURE INCREASED 65 0.0117
329 VASODILATATION 29 0.0115
330 LIVEDO RETICULARIS 24 0.0115
331 HYPOVOLAEMIC SHOCK 55 0.0115
332 BLOOD PRESSURE DECREASED 760 0.0114
333 EXTRASYSTOLES 79 0.0113
334 DRUG INTERACTION 1793 0.0113
335 TONGUE OEDEMA 43 0.0113
336 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 57 0.0112
337 BUNDLE BRANCH BLOCK RIGHT 51 0.0111
338 CATATONIA 58 0.0110
339 GRAND MAL CONVULSION 99 0.0107
340 HYPOTONIA 107 0.0107
341 NORMAL NEWBORN 58 0.0107
342 ESCHERICHIA BACTERAEMIA 25 0.0106
343 MYOCARDIAL ISCHAEMIA 121 0.0106
344 POST PROCEDURAL HAEMORRHAGE 123 0.0106
345 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 28 0.0105
346 HYPERVENTILATION 61 0.0105
347 PULMONARY OEDEMA 466 0.0104
348 HYPOPNOEA 36 0.0104
349 INCORRECT DRUG ADMINISTRATION RATE 44 0.0103
350 CARDIOPULMONARY FAILURE 40 0.0102
351 ASPIRATION 112 0.0102
352 PNEUMOTHORAX 162 0.0102
353 RESPIRATORY DISTRESS 281 0.0102
354 METABOLIC DISORDER 59 0.0101
355 HEPATIC FAILURE 305 0.0101
356 CARDIAC FAILURE ACUTE 67 0.0100
357 SEPTIC SHOCK 435 0.0100
358 THROMBOPHLEBITIS 35 0.0100
359 MUSCLE CONTRACTIONS INVOLUNTARY 35 0.0099
360 HYPERBILIRUBINAEMIA 103 0.0099
361 PRODUCT PACKAGING CONFUSION 24 0.0099
362 DEPRESSED LEVEL OF CONSCIOUSNESS 390 0.0098
363 BILIRUBIN CONJUGATED INCREASED 23 0.0098
364 RASH MACULO-PAPULAR 218 0.0098
365 BLOOD LACTATE DEHYDROGENASE INCREASED 155 0.0098
366 LEUKOCYTOSIS 176 0.0097
367 ORGAN FAILURE 39 0.0097
368 METABOLIC ENCEPHALOPATHY 29 0.0097
369 DELIRIUM 335 0.0096
370 HEPATITIS C 116 0.0096
371 DRUG LEVEL BELOW THERAPEUTIC 53 0.0096
372 PERIPHERAL ISCHAEMIA 39 0.0095
373 ANTINUCLEAR ANTIBODY POSITIVE 31 0.0095
374 DIASTOLIC DYSFUNCTION 29 0.0094
375 URINE OUTPUT DECREASED 82 0.0094
376 EOSINOPHILIA 162 0.0092
377 INJURY 643 0.0091
378 HISTIOCYTOSIS HAEMATOPHAGIC 27 0.0091
379 ELECTROCARDIOGRAM ABNORMAL 71 0.0090
380 ILEUS 112 0.0090
381 HYPERTENSIVE CRISIS 100 0.0090
382 LIP OEDEMA 38 0.0090
383 COMA 426 0.0089
384 WEIGHT BEARING DIFFICULTY 24 0.0089
385 MOTOR DYSFUNCTION 90 0.0088
386 PARALYSIS 126 0.0088
387 BLOOD PHOSPHORUS INCREASED 24 0.0088
388 PNEUMONIA ASPIRATION 219 0.0088
389 HYPERPYREXIA 37 0.0087
390 CHOLESTASIS 167 0.0087
391 CAESAREAN SECTION 101 0.0087
392 FACE OEDEMA 146 0.0086
393 HEPATITIS CHOLESTATIC 52 0.0086
394 RENAL FAILURE 1129 0.0085
395 LACTIC ACIDOSIS 275 0.0085
396 LUNG INFILTRATION 75 0.0085
397 SCOLIOSIS 52 0.0084
398 AGITATION 615 0.0084
399 RENAL IMPAIRMENT 702 0.0083
400 CARDIAC DYSFUNCTION 31 0.0083
401 FOETAL EXPOSURE DURING PREGNANCY 668 0.0082
402 CONGENITAL ANOMALY 63 0.0081
403 HEPATITIS 207 0.0081
404 ENCEPHALITIS 55 0.0079
405 PULMONARY HAEMORRHAGE 62 0.0079
406 RALES 46 0.0079
407 HYPERVOLAEMIA 39 0.0079
408 CONJUNCTIVAL HYPERAEMIA 28 0.0078
409 HYPOALBUMINAEMIA 61 0.0078
410 INTRACARDIAC THROMBUS 24 0.0078
411 PREMATURE LABOUR 44 0.0078
412 HYPERTRANSAMINASAEMIA 54 0.0078
413 DRUG USE DISORDER 65 0.0077
414 NECROSIS 43 0.0077
415 PSEUDOMONAS INFECTION 66 0.0077
416 EMBOLIC STROKE 27 0.0077
417 PANCREATITIS ACUTE 170 0.0076
418 BLOOD ALBUMIN DECREASED 60 0.0076
419 OLIGOHYDRAMNIOS 25 0.0075
420 BLOOD POTASSIUM INCREASED 121 0.0074
421 EYE MOVEMENT DISORDER 51 0.0074
422 CEREBRAL HAEMATOMA 25 0.0074
423 DISEASE COMPLICATION 34 0.0074
424 CARDIOMEGALY 91 0.0074
425 FIBRIN D DIMER INCREASED 26 0.0073
426 ALTERED STATE OF CONSCIOUSNESS 157 0.0072
427 CARDIOTOXICITY 64 0.0072
428 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 391 0.0071
429 ACUTE KIDNEY INJURY 1089 0.0071
430 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 43 0.0071
431 BODY TEMPERATURE INCREASED 144 0.0071
432 PROTHROMBIN TIME PROLONGED 42 0.0070
433 UNEVALUABLE EVENT 530 0.0070
434 OCCUPATIONAL EXPOSURE TO PRODUCT 45 0.0070
435 ILEUS PARALYTIC 31 0.0069
436 BLOOD CALCIUM DECREASED 78 0.0069
437 STEVENS-JOHNSON SYNDROME 154 0.0069
438 TRICUSPID VALVE INCOMPETENCE 55 0.0069
439 ALANINE AMINOTRANSFERASE INCREASED 425 0.0069
440 BLOOD BILIRUBIN INCREASED 185 0.0068
441 DYSKINESIA 278 0.0068
442 NO THERAPEUTIC RESPONSE 83 0.0068
443 ANGIOEDEMA 299 0.0068
444 MONOPLEGIA 29 0.0067
445 DERMATITIS BULLOUS 48 0.0066
446 DRUG TOXICITY 90 0.0066
447 COVID-19 PNEUMONIA 78 0.0066
448 RESPIRATORY RATE INCREASED 58 0.0065
449 SALIVARY HYPERSECRETION 65 0.0065
450 ASPARTATE AMINOTRANSFERASE INCREASED 344 0.0065
451 THROMBOTIC MICROANGIOPATHY 63 0.0065
452 MITRAL VALVE INCOMPETENCE 73 0.0064
453 LEUKOENCEPHALOPATHY 24 0.0064
454 EJECTION FRACTION DECREASED 100 0.0064
455 INFUSION SITE EXTRAVASATION 40 0.0064
456 HYDROCEPHALUS 35 0.0064
457 ANGIOPATHY 36 0.0064
458 SUBARACHNOID HAEMORRHAGE 65 0.0064
459 DUODENAL ULCER 45 0.0064
460 HYPERLIPIDAEMIA 76 0.0064
461 TOXIC SKIN ERUPTION 64 0.0063
462 TRANSAMINASES INCREASED 141 0.0063
463 HEART RATE DECREASED 219 0.0062
464 MATERNAL EXPOSURE DURING PREGNANCY 543 0.0061
465 ISCHAEMIA 28 0.0061
466 HYPOPHOSPHATAEMIA 45 0.0061
467 HYPERAESTHESIA 50 0.0061
468 BREATH SOUNDS ABNORMAL 30 0.0061
469 BACTERAEMIA 72 0.0061
470 SPINAL OSTEOARTHRITIS 53 0.0060
471 CHROMATURIA 136 0.0060
472 CEREBRAL ATROPHY 24 0.0060
473 AZOTAEMIA 24 0.0060
474 IRON DEFICIENCY 27 0.0060
475 ENTEROCOCCAL INFECTION 29 0.0060
476 EXPOSURE DURING PREGNANCY 373 0.0060
477 ARRHYTHMIA 284 0.0060
478 MENTAL STATUS CHANGES 166 0.0060
479 CARDIOMYOPATHY 88 0.0059
480 BLOOD MAGNESIUM DECREASED 51 0.0059
481 AMMONIA INCREASED 30 0.0059
482 NEUROTOXICITY 102 0.0058
483 EUGLYCAEMIC DIABETIC KETOACIDOSIS 24 0.0058
484 SCREAMING 37 0.0058
485 DERMATITIS EXFOLIATIVE 29 0.0058
486 GUILLAIN-BARRE SYNDROME 28 0.0058
487 PNEUMONIA BACTERIAL 53 0.0058
488 NEUROLOGICAL SYMPTOM 33 0.0058
489 WRONG PRODUCT ADMINISTERED 39 0.0058
490 PULMONARY CONGESTION 76 0.0058
491 FOETAL GROWTH RESTRICTION 35 0.0058
492 HEPATOTOXICITY 128 0.0057
493 CREATININE RENAL CLEARANCE DECREASED 23 0.0057
494 MALABSORPTION 30 0.0057
495 ARTERIOSCLEROSIS CORONARY ARTERY 38 0.0057
496 MIOSIS 46 0.0057
497 JAUNDICE 154 0.0057
498 RIGHT VENTRICULAR FAILURE 40 0.0057
499 CARDIAC TAMPONADE 27 0.0057
500 DRUG-INDUCED LIVER INJURY 177 0.0056
501 AORTIC VALVE INCOMPETENCE 24 0.0056
502 DIALYSIS 79 0.0056
503 DRUG LEVEL INCREASED 92 0.0056
504 BLOOD TRIGLYCERIDES INCREASED 98 0.0055
505 ATRIAL FLUTTER 44 0.0055
506 RESPIRATION ABNORMAL 38 0.0055
507 HEPATIC ENCEPHALOPATHY 50 0.0054
508 PERFORMANCE STATUS DECREASED 25 0.0054
509 SEPSIS 596 0.0053
510 ATAXIA 63 0.0053
511 HYPOKALAEMIA 245 0.0053
512 LIVER INJURY 129 0.0053
513 CONVULSION 297 0.0052
514 COLITIS ISCHAEMIC 35 0.0052
515 TOXICITY TO VARIOUS AGENTS 872 0.0052
516 RESPIRATORY DISORDER 154 0.0051
517 ADRENAL INSUFFICIENCY 62 0.0051
518 EPILEPSY 156 0.0051
519 ELECTROLYTE IMBALANCE 59 0.0051
520 RENAL FAILURE CHRONIC 39 0.0051
521 STAPHYLOCOCCAL SEPSIS 25 0.0051
522 ATRIAL FIBRILLATION 490 0.0050
523 HYPOMAGNESAEMIA 69 0.0050
524 CHOLECYSTITIS ACUTE 28 0.0049
525 CLOSTRIDIUM DIFFICILE COLITIS 52 0.0049
526 EYELID OEDEMA 57 0.0049
527 ENDOCARDITIS 25 0.0049
528 LIPASE INCREASED 37 0.0048
529 MATERNAL DRUGS AFFECTING FOETUS 37 0.0048
530 HEMIPLEGIA 40 0.0048
531 PULMONARY HYPERTENSION 100 0.0048
532 POOR QUALITY DRUG ADMINISTERED 31 0.0048
533 HEPATIC FUNCTION ABNORMAL 178 0.0048
534 CARDIOVASCULAR DISORDER 121 0.0048
535 POISONING DELIBERATE 45 0.0047
536 HAEMATEMESIS 120 0.0047
537 INTESTINAL PERFORATION 53 0.0047
538 CONCOMITANT DISEASE AGGRAVATED 29 0.0047
539 GENERALISED OEDEMA 58 0.0047
540 HEPATOMEGALY 46 0.0047
541 DECUBITUS ULCER 38 0.0047
542 HAEMOLYSIS 36 0.0047
543 BLOOD UREA INCREASED 78 0.0047
544 SEDATION 122 0.0047
545 DRUG EXPOSURE DURING PREGNANCY 158 0.0046
546 ANAL ABSCESS 25 0.0046
547 MUSCLE TWITCHING 106 0.0046
548 SEIZURE 530 0.0046
549 ACUTE CORONARY SYNDROME 38 0.0046
550 ABORTION INDUCED 43 0.0046
551 ASCITES 133 0.0045
552 BLOOD ALKALINE PHOSPHATASE INCREASED 111 0.0045
553 MYOCARDITIS 51 0.0044
554 THROMBOCYTOPENIA 495 0.0044
555 MYOPATHY 38 0.0044
556 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 45 0.0044
557 EMPHYSEMA 44 0.0044
558 AGRANULOCYTOSIS 81 0.0044
559 PLEURAL EFFUSION 265 0.0044
560 MEDICATION ERROR 241 0.0043
561 LIVE BIRTH 36 0.0043
562 CEREBRAL INFARCTION 105 0.0043
563 DRUG RESISTANCE 110 0.0043
564 POLYP 28 0.0043
565 FLUID OVERLOAD 62 0.0043
566 ESCHERICHIA INFECTION 35 0.0043
567 REBOUND EFFECT 48 0.0042
568 PERIORBITAL SWELLING 24 0.0042
569 BLOOD CREATININE INCREASED 277 0.0042
570 GAMMA-GLUTAMYLTRANSFERASE INCREASED 94 0.0042
571 HAEMOPTYSIS 118 0.0042
572 PALLOR 115 0.0042
573 APHASIA 127 0.0042
574 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 37 0.0042
575 LARGE INTESTINE PERFORATION 29 0.0042
576 HYPERGLYCAEMIA 152 0.0042
577 ENTEROCOLITIS 24 0.0042
578 ACUTE MYOCARDIAL INFARCTION 122 0.0041
579 RASH PUSTULAR 30 0.0041
580 EMOTIONAL DISTRESS 498 0.0041
581 MALNUTRITION 46 0.0041
582 LIVER FUNCTION TEST ABNORMAL 119 0.0041
583 DISORIENTATION 162 0.0041
584 END STAGE RENAL DISEASE 74 0.0041
585 POST-TRAUMATIC STRESS DISORDER 27 0.0040
586 HAEMOLYTIC ANAEMIA 36 0.0040
587 INCOHERENT 26 0.0040
588 BRONCHOPULMONARY ASPERGILLOSIS 31 0.0040
589 ERYTHEMA MULTIFORME 37 0.0040
590 CEREBRAL HAEMORRHAGE 139 0.0039
591 CHILLS 455 0.0039
592 LIVER FUNCTION TEST INCREASED 82 0.0038
593 ULCER 60 0.0038
594 TUBULOINTERSTITIAL NEPHRITIS 70 0.0037
595 HYPOCALCAEMIA 70 0.0037
596 INTERVERTEBRAL DISC DEGENERATION 34 0.0037
597 POISONING 46 0.0037
598 BLINDNESS TRANSIENT 27 0.0037
599 DERMATITIS ALLERGIC 46 0.0037
600 OROPHARYNGEAL DISCOMFORT 33 0.0036
601 HIATUS HERNIA 47 0.0036
602 HYPERCHOLESTEROLAEMIA 35 0.0036
603 HAEMATURIA 124 0.0036
604 RESTLESSNESS 132 0.0036
605 SENSORY LOSS 29 0.0036
606 CARDIAC FAILURE 287 0.0036
607 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 61 0.0036
608 PSYCHOMOTOR HYPERACTIVITY 59 0.0036
609 TUMOUR LYSIS SYNDROME 31 0.0035
610 DIVERTICULUM 25 0.0035
611 ARTERIOSCLEROSIS 33 0.0035
612 DRUG ERUPTION 62 0.0035
613 HEPATIC STEATOSIS 65 0.0035
614 HEMIPARESIS 59 0.0035
615 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 26 0.0035
616 EXTRAPYRAMIDAL DISORDER 86 0.0035
617 ANAL INCONTINENCE 31 0.0034
618 NERVOUS SYSTEM DISORDER 107 0.0034
619 HEART RATE INCREASED 338 0.0034
620 CEREBRAL DISORDER 25 0.0034
621 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 24 0.0033
622 ABSCESS 53 0.0033
623 THERAPY NON-RESPONDER 149 0.0033
624 PANCREATITIS 175 0.0033
625 WHEEZING 196 0.0033
626 HICCUPS 27 0.0033
627 QUALITY OF LIFE DECREASED 44 0.0033
628 RENAL CYST 26 0.0033
629 BLOOD PRESSURE DIASTOLIC DECREASED 24 0.0032
630 RASH ERYTHEMATOUS 155 0.0032
631 PYREXIA 1116 0.0032
632 URTICARIA 538 0.0032
633 HAEMATOMA 83 0.0032
634 CYTOKINE RELEASE SYNDROME 64 0.0032
635 SWOLLEN TONGUE 99 0.0032
636 LOSS OF CONSCIOUSNESS 406 0.0032
637 RASH GENERALISED 81 0.0031
638 BLOOD PRESSURE SYSTOLIC INCREASED 61 0.0031
639 DRUG ABUSE 259 0.0031
640 HYPERTENSION 659 0.0031
641 HYPOKINESIA 45 0.0031
642 MYASTHENIA GRAVIS 25 0.0031
643 MUSCLE SPASTICITY 38 0.0031
644 HAEMATOCRIT DECREASED 61 0.0031
645 ERYTHEMA 630 0.0031
646 LYMPHOPENIA 43 0.0030
647 WRONG DRUG ADMINISTERED 27 0.0030
648 DYSARTHRIA 114 0.0030
649 COGNITIVE DISORDER 141 0.0030
650 AGGRESSION 151 0.0030
651 ACCIDENTAL OVERDOSE 110 0.0030
652 WHITE BLOOD CELL COUNT INCREASED 115 0.0030
653 BLOOD DISORDER 24 0.0030
654 PROCEDURAL PAIN 83 0.0030
655 DISABILITY 58 0.0029
656 POLYNEUROPATHY 35 0.0029
657 UPPER GASTROINTESTINAL HAEMORRHAGE 49 0.0029
658 LIVER DISORDER 129 0.0029
659 URINARY RETENTION 97 0.0029
660 INTENTIONAL OVERDOSE 186 0.0029
661 NEPHROPATHY TOXIC 32 0.0028
662 SKIN LACERATION 31 0.0028
663 STAPHYLOCOCCAL INFECTION 94 0.0028
664 INCONTINENCE 30 0.0028
665 UROSEPSIS 26 0.0028
666 AKATHISIA 38 0.0028
667 NEPHROPATHY 26 0.0028
668 C-REACTIVE PROTEIN INCREASED 101 0.0028
669 PARKINSONISM 27 0.0028
670 THERAPEUTIC PRODUCT EFFECT DECREASED 124 0.0028
671 URINARY INCONTINENCE 82 0.0028
672 OVERDOSE 597 0.0028
673 COMPLETED SUICIDE 230 0.0028
674 DEEP VEIN THROMBOSIS 179 0.0028
675 ISCHAEMIC STROKE 49 0.0027
676 HAEMORRHAGE INTRACRANIAL 41 0.0027
677 HAEMORRHAGE 283 0.0027
678 DRUG EFFECT DECREASED 145 0.0027
679 CHOLECYSTITIS 32 0.0027
680 MUSCLE ATROPHY 34 0.0027
681 PRODUCT USE IN UNAPPROVED INDICATION 664 0.0027
682 HYPERCALCAEMIA 33 0.0027
683 INTERNATIONAL NORMALISED RATIO INCREASED 76 0.0027
684 OEDEMA 144 0.0027
685 ANXIETY 754 0.0026
686 CONTRAINDICATED PRODUCT ADMINISTERED 80 0.0026
687 SECRETION DISCHARGE 33 0.0026
688 MOVEMENT DISORDER 84 0.0026
689 NERVE INJURY 29 0.0026
690 HEPATIC CIRRHOSIS 49 0.0026
691 SUICIDE ATTEMPT 158 0.0026
692 GASTROINTESTINAL HAEMORRHAGE 215 0.0026
693 SPLENOMEGALY 30 0.0026
694 PULMONARY EMBOLISM 243 0.0026
695 WOUND INFECTION 28 0.0026
696 PERICARDIAL EFFUSION 59 0.0025
697 HYPONATRAEMIA 143 0.0025
698 CONFUSIONAL STATE 408 0.0025
699 SUBDURAL HAEMATOMA 36 0.0025
700 HAEMORRHOIDS 49 0.0025
701 ADVERSE REACTION 33 0.0025
702 DRUG INEFFECTIVE 3257 0.0025
703 SLEEP APNOEA SYNDROME 47 0.0025
704 DRUG LEVEL DECREASED 25 0.0025
705 GLOMERULAR FILTRATION RATE DECREASED 30 0.0024
706 LIP SWELLING 81 0.0024
707 PETECHIAE 25 0.0024
708 CORONARY ARTERY DISEASE 72 0.0024
709 SOMNOLENCE 478 0.0024
710 JOINT DISLOCATION 25 0.0024
711 NEUTROPHIL COUNT INCREASED 24 0.0023
712 BODY TEMPERATURE DECREASED 23 0.0023
713 BLOOD PRESSURE FLUCTUATION 55 0.0023
714 HEPATIC ENZYME INCREASED 154 0.0023
715 CONDITION AGGRAVATED 686 0.0023
716 DIPLOPIA 58 0.0022
717 PANCYTOPENIA 124 0.0022
718 HYPERTHYROIDISM 32 0.0022
719 OFF LABEL USE 1921 0.0022
720 HAEMOGLOBIN DECREASED 225 0.0022
721 SOPOR 29 0.0022
722 CHRONIC KIDNEY DISEASE 166 0.0022
723 HYPOGLYCAEMIA 105 0.0022
724 MENTAL IMPAIRMENT 52 0.0021
725 DEVICE RELATED INFECTION 33 0.0021
726 PSYCHOTIC DISORDER 63 0.0021
727 WITHDRAWAL SYNDROME 89 0.0021
728 LEUKOPENIA 106 0.0021
729 GENERAL PHYSICAL HEALTH DETERIORATION 243 0.0021
730 CYST 26 0.0021
731 DYSPHAGIA 198 0.0021
732 DRUG ADMINISTRATION ERROR 64 0.0021
733 SPEECH DISORDER 108 0.0021
734 OSTEOARTHRITIS 87 0.0021
735 GASTRIC ULCER 39 0.0020
736 MUSCULAR WEAKNESS 233 0.0020
737 PNEUMONIA 663 0.0020
738 INTERSTITIAL LUNG DISEASE 99 0.0020
739 HYPERSENSITIVITY 377 0.0020
740 PHARYNGEAL OEDEMA 31 0.0020
741 CHOLELITHIASIS 66 0.0020
742 ANAEMIA 381 0.0020
743 HYPERHIDROSIS 256 0.0020
744 MELAENA 43 0.0020
745 TREATMENT FAILURE 161 0.0019
746 BLOOD PRESSURE INCREASED 297 0.0019
747 BLOOD POTASSIUM DECREASED 58 0.0019
748 ECONOMIC PROBLEM 29 0.0019
749 MANIA 31 0.0019
750 PERITONITIS 39 0.0019
751 WRONG TECHNIQUE IN DRUG USAGE PROCESS 68 0.0019
752 LYMPHOCYTE COUNT DECREASED 33 0.0019
753 HALLUCINATION, VISUAL 39 0.0018
754 SKIN REACTION 26 0.0018
755 PROTEINURIA 35 0.0018
756 PLATELET COUNT INCREASED 24 0.0018
757 RETCHING 39 0.0018
758 BACTERIAL INFECTION 34 0.0018
759 SENSORY DISTURBANCE 29 0.0018
760 ABDOMINAL DISTENSION 188 0.0018
761 DRUG WITHDRAWAL SYNDROME 157 0.0018
762 HYPOTHYROIDISM 57 0.0018
763 PLATELET COUNT DECREASED 189 0.0018
764 AMNESIA 115 0.0018
765 IMPAIRED GASTRIC EMPTYING 24 0.0018
766 DRUG WITHDRAWAL SYNDROME NEONATAL 26 0.0018
767 GASTRITIS 46 0.0017
768 RASH 762 0.0017
769 MUSCLE TIGHTNESS 28 0.0017
770 PNEUMONITIS 47 0.0017
771 COORDINATION ABNORMAL 24 0.0017
772 FLUSHING 174 0.0017
773 PRESCRIBED OVERDOSE 33 0.0017
774 VOMITING 797 0.0017
775 LETHARGY 97 0.0017
776 PRODUCT ADMINISTRATION ERROR 34 0.0017
777 INCORRECT ROUTE OF DRUG ADMINISTRATION 60 0.0017
778 LUNG DISORDER 82 0.0017
779 CELLULITIS 84 0.0017
780 DIVERTICULITIS 46 0.0017
781 FEBRILE NEUTROPENIA 110 0.0017
782 PULMONARY ARTERIAL HYPERTENSION 24 0.0017
783 RASH PAPULAR 37 0.0016
784 OSTEOPENIA 25 0.0016
785 PAIN 1006 0.0016
786 SWELLING FACE 106 0.0016
787 TREMOR 269 0.0016
788 DRUG EFFECT LESS THAN EXPECTED 24 0.0016
789 CONJUNCTIVITIS 30 0.0016
790 LUNG INFECTION 25 0.0016
791 INFLAMMATION 83 0.0016
792 CLOSTRIDIUM DIFFICILE INFECTION 35 0.0016
793 RASH MACULAR 56 0.0016
794 CARDIAC FAILURE CONGESTIVE 124 0.0015
795 RESTLESS LEGS SYNDROME 28 0.0015
796 SNEEZING 34 0.0015
797 DEVICE FAILURE 23 0.0015
798 IMPAIRED WORK ABILITY 32 0.0015
799 SCAR 25 0.0015
800 MENTAL DISORDER 63 0.0014
801 HALLUCINATION 109 0.0014
802 TREATMENT NONCOMPLIANCE 79 0.0014
803 OSTEOMYELITIS 26 0.0014
804 BONE MARROW FAILURE 29 0.0014
805 DEPRESSION 324 0.0014
806 PRODUCT QUALITY ISSUE 192 0.0014
807 MOOD SWINGS 45 0.0014
808 DYSPNOEA 794 0.0014
809 COLITIS 53 0.0014
810 EPISTAXIS 104 0.0014
811 PHARMACEUTICAL PRODUCT COMPLAINT 36 0.0014
812 OSTEONECROSIS OF JAW 34 0.0014
813 BLISTER 77 0.0014
814 INTENTIONAL PRODUCT MISUSE 120 0.0014
815 CEREBROVASCULAR ACCIDENT 232 0.0014
816 GASTROOESOPHAGEAL REFLUX DISEASE 110 0.0014
817 MYOCARDIAL INFARCTION 237 0.0014
818 LYMPHADENOPATHY 48 0.0014
819 DYSURIA 49 0.0013
820 OEDEMA PERIPHERAL 162 0.0013
821 FEELING COLD 37 0.0013
822 HEART RATE IRREGULAR 30 0.0013
823 DYSPNOEA EXERTIONAL 50 0.0013
824 BONE DISORDER 24 0.0013
825 ABNORMAL BEHAVIOUR 52 0.0013
826 COUGH 366 0.0013
827 COLD SWEAT 23 0.0013
828 BLOOD SODIUM DECREASED 24 0.0013
829 NEUTROPENIA 173 0.0013
830 SYNCOPE 127 0.0013
831 FUNGAL INFECTION 42 0.0013
832 BLOOD PRESSURE ABNORMAL 25 0.0013
833 ABDOMINAL PAIN 291 0.0012
834 THERAPEUTIC RESPONSE DECREASED 75 0.0012
835 RED BLOOD CELL COUNT DECREASED 35 0.0012
836 INFECTION 177 0.0012
837 PAIN IN JAW 34 0.0012
838 TINNITUS 55 0.0012
839 LIMB DISCOMFORT 37 0.0012
840 RECTAL HAEMORRHAGE 51 0.0012
841 DEAFNESS 31 0.0012
842 DEHYDRATION 157 0.0012
843 CARDIAC DISORDER 110 0.0012
844 SKIN ULCER 30 0.0012
845 THROMBOSIS 93 0.0012
846 MYALGIA 194 0.0011
847 RENAL DISORDER 53 0.0011
848 FLATULENCE 64 0.0011
849 FAECES DISCOLOURED 24 0.0011
850 IRRITABILITY 66 0.0011
851 TRANSIENT ISCHAEMIC ATTACK 37 0.0011
852 INTENTIONAL PRODUCT USE ISSUE 96 0.0011
853 DISTURBANCE IN ATTENTION 59 0.0011
854 CHEST PAIN 201 0.0011
855 BACK PAIN 247 0.0011
856 INTERVERTEBRAL DISC PROTRUSION 23 0.0011
857 PRODUCT USE ISSUE 197 0.0010
858 NAUSEA 826 0.0010
859 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74 0.0010
860 ASTHENIA 391 0.0010
861 OROPHARYNGEAL PAIN 96 0.0010
862 RASH PRURITIC 56 0.0010
863 PRODUCTIVE COUGH 49 0.0010
864 SKIN DISCOLOURATION 47 0.0010
865 URINARY TRACT INFECTION 171 0.0010
866 WOUND 28 0.0010
867 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 29 0.0010
868 DISEASE RECURRENCE 47 0.0010
869 PRESYNCOPE 24 0.0010
870 SKIN LESION 27 0.0010
871 HEAD INJURY 31 0.0010
872 SLEEP DISORDER 69 0.0010
873 ANGINA PECTORIS 28 0.0010
874 IMPAIRED HEALING 32 0.0010
875 EMOTIONAL DISORDER 30 0.0010
876 MUSCULOSKELETAL STIFFNESS 84 0.0010
877 DIABETES MELLITUS 73 0.0010
878 DIABETIC KETOACIDOSIS 23 0.0010
879 PARAESTHESIA 150 0.0010
880 UPPER RESPIRATORY TRACT INFECTION 44 0.0010
881 CHEST DISCOMFORT 97 0.0009
882 NEUTROPHIL COUNT DECREASED 38 0.0009
883 ASTHMA 105 0.0009
884 NERVOUSNESS 48 0.0009
885 HYPOAESTHESIA 136 0.0009
886 DRUG EFFECT INCOMPLETE 32 0.0009
887 PANIC ATTACK 32 0.0009
888 DYSPHONIA 51 0.0009
889 DISCOMFORT 53 0.0009
890 NO ADVERSE EVENT 157 0.0009
891 FEELING HOT 53 0.0009
892 SWELLING 80 0.0009
893 TARDIVE DYSKINESIA 24 0.0008
894 DEATH 732 0.0008
895 MOBILITY DECREASED 60 0.0008
896 MEMORY IMPAIRMENT 114 0.0008
897 INTESTINAL OBSTRUCTION 31 0.0008
898 BLINDNESS 33 0.0008
899 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 42 0.0008
900 MUSCLE SPASMS 147 0.0008
901 GAIT DISTURBANCE 153 0.0008
902 POLLAKIURIA 33 0.0008
903 LABORATORY TEST ABNORMAL 23 0.0008
904 CONSTIPATION 169 0.0008
905 INFUSION RELATED REACTION 50 0.0008
906 NECK PAIN 42 0.0008
907 SURGERY 44 0.0007
908 PRODUCT SUBSTITUTION ISSUE 43 0.0007
909 CRYING 27 0.0007
910 RHINORRHOEA 48 0.0007
911 DISEASE PROGRESSION 87 0.0007
912 ACCIDENTAL EXPOSURE TO PRODUCT 75 0.0007
913 PALPITATIONS 85 0.0007
914 HAEMATOCHEZIA 40 0.0007
915 NIGHTMARE 25 0.0007
916 SKIN DISORDER 24 0.0007
917 NEPHROLITHIASIS 33 0.0007
918 VAGINAL HAEMORRHAGE 31 0.0007
919 INFLUENZA LIKE ILLNESS 58 0.0007
920 WHITE BLOOD CELL COUNT DECREASED 76 0.0007
921 PRURITUS 267 0.0007
922 MUSCULOSKELETAL PAIN 36 0.0007
923 WEIGHT DECREASED 190 0.0007
924 VISION BLURRED 91 0.0007
925 BURNING SENSATION 46 0.0007
926 DIZZINESS 325 0.0007
927 ILL-DEFINED DISORDER 39 0.0006
928 MIGRAINE 61 0.0006
929 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
930 VISUAL IMPAIRMENT 79 0.0006
931 ABDOMINAL PAIN UPPER 131 0.0006
932 FLUID RETENTION 32 0.0006
933 BRONCHITIS 46 0.0006
934 INSOMNIA 163 0.0006
935 NEUROPATHY PERIPHERAL 58 0.0006
936 DRUG DEPENDENCE 98 0.0006
937 OSTEOPOROSIS 25 0.0006
938 THROAT IRRITATION 27 0.0006
939 BALANCE DISORDER 52 0.0006
940 ROAD TRAFFIC ACCIDENT 25 0.0006
941 HEADACHE 371 0.0006
942 DEVICE ISSUE 53 0.0006
943 ADVERSE DRUG REACTION 53 0.0006
944 FALL 194 0.0006
945 CATARACT 34 0.0006
946 GASTROINTESTINAL DISORDER 51 0.0006
947 EXTRA DOSE ADMINISTERED 23 0.0006
948 DIARRHOEA 364 0.0006
949 DRUG INTOLERANCE 54 0.0006
950 VERTIGO 34 0.0006
951 ARTHROPATHY 31 0.0006
952 DYSPEPSIA 54 0.0005
953 COVID-19 95 0.0005
954 DEVICE MALFUNCTION 38 0.0005
955 DECREASED APPETITE 125 0.0005
956 ECZEMA 28 0.0005
957 MALAISE 231 0.0005
958 PAIN IN EXTREMITY 153 0.0005
959 THERAPY CESSATION 26 0.0005
960 BLOOD GLUCOSE INCREASED 95 0.0005
961 DRY MOUTH 39 0.0005
962 STOMATITIS 29 0.0005
963 SUICIDAL IDEATION 43 0.0005
964 DRY EYE 23 0.0005
965 INCORRECT DOSE ADMINISTERED 104 0.0005
966 HERPES ZOSTER 26 0.0005
967 SKIN EXFOLIATION 38 0.0004
968 EYE PAIN 25 0.0004
969 CONTUSION 42 0.0004
970 ADVERSE EVENT 39 0.0004
971 UNDERDOSE 30 0.0004
972 INJECTION SITE SWELLING 31 0.0004
973 DYSGEUSIA 30 0.0004
974 PERIPHERAL SWELLING 62 0.0004
975 FATIGUE 305 0.0004
976 SINUSITIS 40 0.0004
977 INFLUENZA 42 0.0004
978 FEELING ABNORMAL 85 0.0004
979 RHEUMATOID ARTHRITIS 39 0.0003
980 ABDOMINAL DISCOMFORT 57 0.0003
981 ARTHRALGIA 140 0.0003
982 WEIGHT INCREASED 75 0.0003
983 INJECTION SITE REACTION 23 0.0003
984 MALIGNANT NEOPLASM PROGRESSION 33 0.0003
985 ARTHRITIS 25 0.0003
986 JOINT SWELLING 27 0.0002
987 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 44 0.0002
988 NASOPHARYNGITIS 39 0.0002
989 ALOPECIA 39 0.0002
990 HOSPITALISATION 27 0.0002
991 PRODUCT DOSE OMISSION ISSUE 48 0.0002
992 INJECTION SITE PAIN 48 0.0002
993 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 27 0.0001